Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.48), $0.18 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $45.78 million versus the consensus estimate of $48.45 million.

For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.